Cytokine Production in Response to Soluble Leishmania Aethiopica Antigen by Whole Blood Cells from Patients with Different Clinical Presentations of Cutaneous Leishmaniasis.
Bizuayehu Gashaw, Endalew Yizengaw, Edward Cruz Cervera, Endalkachew Nibret, Dessalegn Tamiru, Ingrid Müller, James A Cotton, Yegnasew Takele, Pascale Kropf
{"title":"Cytokine Production in Response to Soluble Leishmania Aethiopica Antigen by Whole Blood Cells from Patients with Different Clinical Presentations of Cutaneous Leishmaniasis.","authors":"Bizuayehu Gashaw, Endalew Yizengaw, Edward Cruz Cervera, Endalkachew Nibret, Dessalegn Tamiru, Ingrid Müller, James A Cotton, Yegnasew Takele, Pascale Kropf","doi":"10.4269/ajtmh.24-0581","DOIUrl":null,"url":null,"abstract":"<p><p>Cutaneous leishmaniasis (CL), a parasitic disease caused by Leishmania aethiopica, is a major health problem in Ethiopia. It presents mostly as three different clinical forms: localized CL characterized by small lesions that ulcerate; diffuse CL defined by multiple nonulcerating nodules; and mucocutaneous leishmaniasis, where the mucosa of the nose or the mouth is affected. The mechanisms resulting in the development of these different clinical presentation are still poorly understood. Here, we recruited a cohort of CL patients presenting with different forms of CL in northwest Ethiopia as well as cohort of healthy nonendemic controls. We assessed the capacity of whole blood cells from these cohorts to produce cytokines in response to soluble L. aethiopica antigen and compared these levels between the different clinical presentations of CL and healthy nonendemic controls. Our results show that the levels of antigen-specific cytokines produced by whole blood cells from CL patients were higher as compared with controls. However, these cytokine levels were similar among the different clinical presentations. In conclusion, the results of our study indicate that variations in clinical manifestations of CL are not associated with differences in antigen-specific cytokine profiles.</p>","PeriodicalId":7752,"journal":{"name":"American Journal of Tropical Medicine and Hygiene","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Tropical Medicine and Hygiene","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4269/ajtmh.24-0581","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Cutaneous leishmaniasis (CL), a parasitic disease caused by Leishmania aethiopica, is a major health problem in Ethiopia. It presents mostly as three different clinical forms: localized CL characterized by small lesions that ulcerate; diffuse CL defined by multiple nonulcerating nodules; and mucocutaneous leishmaniasis, where the mucosa of the nose or the mouth is affected. The mechanisms resulting in the development of these different clinical presentation are still poorly understood. Here, we recruited a cohort of CL patients presenting with different forms of CL in northwest Ethiopia as well as cohort of healthy nonendemic controls. We assessed the capacity of whole blood cells from these cohorts to produce cytokines in response to soluble L. aethiopica antigen and compared these levels between the different clinical presentations of CL and healthy nonendemic controls. Our results show that the levels of antigen-specific cytokines produced by whole blood cells from CL patients were higher as compared with controls. However, these cytokine levels were similar among the different clinical presentations. In conclusion, the results of our study indicate that variations in clinical manifestations of CL are not associated with differences in antigen-specific cytokine profiles.
期刊介绍:
The American Journal of Tropical Medicine and Hygiene, established in 1921, is published monthly by the American Society of Tropical Medicine and Hygiene. It is among the top-ranked tropical medicine journals in the world publishing original scientific articles and the latest science covering new research with an emphasis on population, clinical and laboratory science and the application of technology in the fields of tropical medicine, parasitology, immunology, infectious diseases, epidemiology, basic and molecular biology, virology and international medicine.
The Journal publishes unsolicited peer-reviewed manuscripts, review articles, short reports, images in Clinical Tropical Medicine, case studies, reports on the efficacy of new drugs and methods of treatment, prevention and control methodologies,new testing methods and equipment, book reports and Letters to the Editor. Topics range from applied epidemiology in such relevant areas as AIDS to the molecular biology of vaccine development.
The Journal is of interest to epidemiologists, parasitologists, virologists, clinicians, entomologists and public health officials who are concerned with health issues of the tropics, developing nations and emerging infectious diseases. Major granting institutions including philanthropic and governmental institutions active in the public health field, and medical and scientific libraries throughout the world purchase the Journal.
Two or more supplements to the Journal on topics of special interest are published annually. These supplements represent comprehensive and multidisciplinary discussions of issues of concern to tropical disease specialists and health issues of developing countries